Key result
Pretreatment with honokiol significantly inhibited LPS-induced neutrophil infiltration and protein leakage (p<0.05) and suppressed MMP-9 activation and oxidative stress in acute lung injury.
Why the study?
Does honokiol pretreatment protect against LPS-induced acute lung injury in a preclinical model?
Does honokiol pretreatment protect against LPS-induced acute lung injury in a preclinical model?
p-value: p=<0.05
Honokiol demonstrates protective effects against LPS-induced acute lung injury in a preclinical model by inhibiting MMP-9 and enhancing antioxidant defenses.
Supports honokiol in rodent ALI models; hypothesis-generating and should not yet change practice.
Despite high morbidity and mortality, no effective options are available for the treatment of acute lung injury (ALI). Therefore, the present study investigated the protective effect of honokiol (HK) on ALI via determination of its effect on several key biomarkers. The results of the study showed that HK significantly inhibited the infiltration of neutrophils and protein leakage induced by lipopolysaccharide (LPS) (p<0.05). The pretreatment with HK considerably boosted the endogenous antioxidant defense system to counteract the oxidative stress in LPS-induced ALI by elevating the levels of superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH). Moreover, the activity of toxic mediators, such as myeloperoxidase (MPO), and lipid peroxidation were significantly inhibited upon treatment with HK. In order to examine the mechanism of action of HK, its effect was quantified using matrix metalloproteinase-9 (MMP-9) activity in bronchoalveolar lavage fluid (BALF) by gelatin zymography. Pretreatment with HK considerably suppressed the activation of MMP-9 in a concentration-dependent manner. These findings suggest that HK protects from lung injury via inhibition of MMP-9, and by enhancing the activity of the endogenous antioxidant defense system.
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) studied Acute lung injury (ALI). Honokiol (HK) vs. Lipopolysaccharide (LPS) alone was evaluated on Infiltration of neutrophils and protein leakage (p=<0.05). Pretreatment with honokiol significantly inhibited LPS-induced neutrophil infiltration and protein leakage (p<0.05) and suppressed MMP-9 activation and oxidative stress in acute lung injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: